J&J Increases European Consumer Stake With Merck Buyout
This article was originally published in The Pink Sheet Daily
Executive Summary
Merck regains rights to future Rx-to-OTC switches in Europe under breakup terms for the J&J MSD Europe joint venture. J&J acquires full ownership, but Merck retains some royalties on J&J-marketed products.